DEXCOM INC (DXCM) Fundamental Analysis & Valuation

NASDAQ:DXCM • US2521311074

Current stock price

63.12 USD
-0.9 (-1.41%)
At close:
63.13 USD
+0.01 (+0.02%)
After Hours:

This DXCM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. DXCM Profitability Analysis

1.1 Basic Checks

  • DXCM had positive earnings in the past year.
  • DXCM had a positive operating cash flow in the past year.
  • DXCM had positive earnings in each of the past 5 years.
  • In the past 5 years DXCM always reported a positive cash flow from operatings.
DXCM Yearly Net Income VS EBIT VS OCF VS FCFDXCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • The Return On Assets of DXCM (13.19%) is better than 93.62% of its industry peers.
  • DXCM has a better Return On Equity (30.46%) than 96.81% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 18.92%, DXCM belongs to the top of the industry, outperforming 96.81% of the companies in the same industry.
  • DXCM had an Average Return On Invested Capital over the past 3 years of 14.59%. This is significantly above the industry average of 9.15%.
  • The 3 year average ROIC (14.59%) for DXCM is below the current ROIC(18.92%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.19%
ROE 30.46%
ROIC 18.92%
ROA(3y)10.24%
ROA(5y)8.29%
ROE(3y)28.01%
ROE(5y)22.13%
ROIC(3y)14.59%
ROIC(5y)11.66%
DXCM Yearly ROA, ROE, ROICDXCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 30

1.3 Margins

  • DXCM has a Profit Margin of 17.94%. This is amongst the best in the industry. DXCM outperforms 93.09% of its industry peers.
  • DXCM's Profit Margin has declined in the last couple of years.
  • DXCM has a Operating Margin of 21.55%. This is amongst the best in the industry. DXCM outperforms 93.62% of its industry peers.
  • In the last couple of years the Operating Margin of DXCM has grown nicely.
  • Looking at the Gross Margin, with a value of 62.09%, DXCM is in the better half of the industry, outperforming 65.43% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DXCM has declined.
Industry RankSector Rank
OM 21.55%
PM (TTM) 17.94%
GM 62.09%
OM growth 3Y15.68%
OM growth 5Y5.09%
PM growth 3Y15.23%
PM growth 5Y-8.86%
GM growth 3Y-1.61%
GM growth 5Y-1.72%
DXCM Yearly Profit, Operating, Gross MarginsDXCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. DXCM Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DXCM is creating value.
  • Compared to 1 year ago, DXCM has less shares outstanding
  • The number of shares outstanding for DXCM remains at a similar level compared to 5 years ago.
  • Compared to 1 year ago, DXCM has an improved debt to assets ratio.
DXCM Yearly Shares OutstandingDXCM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
DXCM Yearly Total Debt VS Total AssetsDXCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 6.27 indicates that DXCM is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 6.27, DXCM belongs to the best of the industry, outperforming 81.91% of the companies in the same industry.
  • DXCM has a debt to FCF ratio of 1.20. This is a very positive value and a sign of high solvency as it would only need 1.20 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.20, DXCM belongs to the top of the industry, outperforming 89.89% of the companies in the same industry.
  • A Debt/Equity ratio of 0.47 indicates that DXCM is not too dependend on debt financing.
  • DXCM has a Debt to Equity ratio (0.47) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1.2
Altman-Z 6.27
ROIC/WACC2.27
WACC8.34%
DXCM Yearly LT Debt VS Equity VS FCFDXCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • A Current Ratio of 1.88 indicates that DXCM should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.88, DXCM is not doing good in the industry: 66.49% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.59 indicates that DXCM should not have too much problems paying its short term obligations.
  • DXCM's Quick ratio of 1.59 is in line compared to the rest of the industry. DXCM outperforms 40.96% of its industry peers.
  • The current and quick ratio evaluation for DXCM is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.59
DXCM Yearly Current Assets VS Current LiabilitesDXCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. DXCM Growth Analysis

3.1 Past

  • DXCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.73%, which is quite good.
  • The Earnings Per Share has been growing by 19.29% on average over the past years. This is quite good.
  • The Revenue has grown by 15.60% in the past year. This is quite good.
  • Measured over the past years, DXCM shows a quite strong growth in Revenue. The Revenue has been growing by 19.33% on average per year.
EPS 1Y (TTM)12.73%
EPS 3Y28.82%
EPS 5Y19.29%
EPS Q2Q%0%
Revenue 1Y (TTM)15.6%
Revenue growth 3Y17.01%
Revenue growth 5Y19.33%
Sales Q2Q%13.12%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.71% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 11.94% on average over the next years. This is quite good.
EPS Next Y36.73%
EPS Next 2Y27.84%
EPS Next 3Y25.1%
EPS Next 5Y21.71%
Revenue Next Year12.62%
Revenue Next 2Y12.47%
Revenue Next 3Y12.38%
Revenue Next 5Y11.94%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DXCM Yearly Revenue VS EstimatesDXCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
DXCM Yearly EPS VS EstimatesDXCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. DXCM Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 33.94, the valuation of DXCM can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of DXCM indicates a somewhat cheap valuation: DXCM is cheaper than 70.21% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.86, DXCM is valued a bit more expensive.
  • With a Price/Forward Earnings ratio of 24.82, DXCM is valued on the expensive side.
  • DXCM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. DXCM is cheaper than 74.47% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.39, DXCM is valued a bit cheaper.
Industry RankSector Rank
PE 33.94
Fwd PE 24.82
DXCM Price Earnings VS Forward Price EarningsDXCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 74.47% of the companies in the same industry are more expensive than DXCM, based on the Enterprise Value to EBITDA ratio.
  • DXCM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DXCM is cheaper than 84.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.55
EV/EBITDA 18.19
DXCM Per share dataDXCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of DXCM may justify a higher PE ratio.
  • DXCM's earnings are expected to grow with 25.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.92
PEG (5Y)1.76
EPS Next 2Y27.84%
EPS Next 3Y25.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DXCM Dividend Analysis

5.1 Amount

  • No dividends for DXCM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DXCM Fundamentals: All Metrics, Ratios and Statistics

DEXCOM INC

NASDAQ:DXCM (4/13/2026, 4:57:27 PM)

After market: 63.13 +0.01 (+0.02%)

63.12

-0.9 (-1.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)04-30
Inst Owners101.29%
Inst Owner Change0.05%
Ins Owners0.25%
Ins Owner Change9.44%
Market Cap24.29B
Revenue(TTM)4.66B
Net Income(TTM)836.30M
Analysts84.86
Price Target89.43 (41.68%)
Short Float %4.26%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.4%
Min EPS beat(2)-32.12%
Max EPS beat(2)5.32%
EPS beat(4)2
Avg EPS beat(4)-6.03%
Min EPS beat(4)-32.12%
Max EPS beat(4)6.77%
EPS beat(8)5
Avg EPS beat(8)-1.11%
EPS beat(12)9
Avg EPS beat(12)9.15%
EPS beat(16)11
Avg EPS beat(16)5.86%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-0.9%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-0.9%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-1.02%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)6
Avg Revenue beat(16)-0.53%
PT rev (1m)1.24%
PT rev (3m)1.01%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)-0.14%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 33.94
Fwd PE 24.82
P/S 5.21
P/FCF 22.55
P/OCF 16.86
P/B 8.85
P/tB 9.16
EV/EBITDA 18.19
EPS(TTM)1.86
EY2.95%
EPS(NY)2.54
Fwd EY4.03%
FCF(TTM)2.8
FCFY4.43%
OCF(TTM)3.74
OCFY5.93%
SpS12.11
BVpS7.14
TBVpS6.89
PEG (NY)0.92
PEG (5Y)1.76
Graham Number17.28
Profitability
Industry RankSector Rank
ROA 13.19%
ROE 30.46%
ROCE 23.93%
ROIC 18.92%
ROICexc 36.12%
ROICexgc 37.75%
OM 21.55%
PM (TTM) 17.94%
GM 62.09%
FCFM 23.11%
ROA(3y)10.24%
ROA(5y)8.29%
ROE(3y)28.01%
ROE(5y)22.13%
ROIC(3y)14.59%
ROIC(5y)11.66%
ROICexc(3y)37.89%
ROICexc(5y)31.72%
ROICexgc(3y)41.79%
ROICexgc(5y)35.48%
ROCE(3y)18.46%
ROCE(5y)14.75%
ROICexgc growth 3Y1.89%
ROICexgc growth 5Y6.96%
ROICexc growth 3Y7.33%
ROICexc growth 5Y6.44%
OM growth 3Y15.68%
OM growth 5Y5.09%
PM growth 3Y15.23%
PM growth 5Y-8.86%
GM growth 3Y-1.61%
GM growth 5Y-1.72%
F-Score8
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1.2
Debt/EBITDA 1.03
Cap/Depr 144.36%
Cap/Sales 7.8%
Interest Coverage 88.12
Cash Conversion 114.67%
Profit Quality 128.81%
Current Ratio 1.88
Quick Ratio 1.59
Altman-Z 6.27
F-Score8
WACC8.34%
ROIC/WACC2.27
Cap/Depr(3y)145.46%
Cap/Depr(5y)210.39%
Cap/Sales(3y)7.74%
Cap/Sales(5y)10.33%
Profit Quality(3y)110.93%
Profit Quality(5y)89.33%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y28.82%
EPS 5Y19.29%
EPS Q2Q%0%
EPS Next Y36.73%
EPS Next 2Y27.84%
EPS Next 3Y25.1%
EPS Next 5Y21.71%
Revenue 1Y (TTM)15.6%
Revenue growth 3Y17.01%
Revenue growth 5Y19.33%
Sales Q2Q%13.12%
Revenue Next Year12.62%
Revenue Next 2Y12.47%
Revenue Next 3Y12.38%
Revenue Next 5Y11.94%
EBIT growth 1Y53.73%
EBIT growth 3Y35.36%
EBIT growth 5Y25.41%
EBIT Next Year67.73%
EBIT Next 3Y32.66%
EBIT Next 5Y25.77%
FCF growth 1Y70.79%
FCF growth 3Y52.34%
FCF growth 5Y31.25%
OCF growth 1Y45.6%
OCF growth 3Y29.1%
OCF growth 5Y24.81%

DEXCOM INC / DXCM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DEXCOM INC?

ChartMill assigns a fundamental rating of 7 / 10 to DXCM.


What is the valuation status of DEXCOM INC (DXCM) stock?

ChartMill assigns a valuation rating of 6 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.


What is the profitability of DXCM stock?

DEXCOM INC (DXCM) has a profitability rating of 8 / 10.


How financially healthy is DEXCOM INC?

The financial health rating of DEXCOM INC (DXCM) is 8 / 10.